Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

Active, not recruiting

Plain-English translation of NCT04023552 on ClinicalTrials.gov ↗ · Source last updated May 2026 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(904 sites)

United States

SEC Clinical Research LLC, Andalusia, Alabama

Grandview Med Group Research LLC, Birmingham, Alabama

Novartis Investigative Site, Birmingham, Alabama

Heart Center Research Llc, Huntsville, Alabama

Novartis Investigative Site, Huntsville, Alabama